Find 170098-38-1 manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Related ProductsRelated Products

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Alvimopan dihydrate, 170098-38-1, Alvimopan hydrate, Alvimopan (dihydrate), Ly 246736 dihydrate, Alvimopan [usan]
Molecular Formula
C25H36N2O6
Molecular Weight
460.6  g/mol
InChI Key
USPVLEIQIUNQGE-DBFLIVQGSA-N
FDA UNII
677C126AET

170098-38-1
Alvimopan is a synthetic trans-3,4-dimethyl-4-(3-hydroxyphenyl) piperidine with peripherally selective opioid mu receptor antagonist activity. Alvimopan is a selective and competitive antagonist at mu-opioid receptors, found in myenteric and submucosal neurons and the immune cells of the lamina propria in the human gut. Upon administration, this agent binds to mu-opioid receptors in the gut, thereby reversing opioid-related disturbances in gut motility. Alvimopan is approximately three to nine times more potent than naloxone.
1 2D Structure

170098-38-1

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-[[(2S)-2-benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]propanoyl]amino]acetic acid;dihydrate
2.1.2 InChI
InChI=1S/C25H32N2O4.2H2O/c1-18-16-27(12-11-25(18,2)21-9-6-10-22(28)14-21)17-20(24(31)26-15-23(29)30)13-19-7-4-3-5-8-19;;/h3-10,14,18,20,28H,11-13,15-17H2,1-2H3,(H,26,31)(H,29,30);2*1H2/t18-,20-,25+;;/m0../s1
2.1.3 InChI Key
USPVLEIQIUNQGE-DBFLIVQGSA-N
2.1.4 Canonical SMILES
CC1CN(CCC1(C)C2=CC(=CC=C2)O)CC(CC3=CC=CC=C3)C(=O)NCC(=O)O.O.O
2.1.5 Isomeric SMILES
C[C@H]1CN(CC[C@@]1(C)C2=CC(=CC=C2)O)C[C@H](CC3=CC=CC=C3)C(=O)NCC(=O)O.O.O
2.2 Other Identifiers
2.2.1 UNII
677C126AET
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Adl 8-2698

2. Adl8-2698

3. Alvimopan

4. Alvimopan Anhydrous

5. Anhydrous Alvimopan

6. Ly 246736

7. Ly-246736

8. Ly246736

9. Trans-3,4-dimethyl-4-(3-hydroxyphenyl) Piperidine

2.3.2 Depositor-Supplied Synonyms

1. Alvimopan Dihydrate

2. 170098-38-1

3. Alvimopan Hydrate

4. Alvimopan (dihydrate)

5. Ly 246736 Dihydrate

6. Alvimopan [usan]

7. Ly-246736 Dihydrate

8. 677c126aet

9. Alvimopan (usan)

10. Adl-8-2698

11. 2-[[(2s)-2-benzyl-3-[(3r,4r)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperi Dyl]propanoyl]amino]acetic Acid Dihydrate

12. 2-[[(2s)-2-benzyl-3-[(3r,4r)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]propanoyl]amino]acetic Acid;dihydrate

13. (((2s)-2-(((3r,4r)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl)methyl)-3-phenylpropanoyl)amino)acetic Acid Dihydrate

14. 2-[[(2s)-2-benzyl-3-[(3r,4r)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]propanoyl]amino]acetic Acid,dihydrate

15. Ly246736

16. Ly-246736

17. Entrareg

18. Alvimopan [usan:inn:ban]

19. Unii-677c126aet

20. Alvimopandihydrate

21. 156053-89-3 (anhydrous)

22. Entereg (tn)

23. Alvimopan [hsdb]

24. Alvimopan [vandf]

25. Alvimopan 2-hydrate

26. Schembl1477341

27. Alvimopan [orange Book]

28. Alvimopan Dihydrate [mi]

29. Dtxsid40168794

30. Hms3886i18

31. Alvimopan Dihydrate [mart.]

32. Bcp10120

33. Sb-767905

34. Hy-76657a

35. S5701

36. Akos015899533

37. Ac-8813

38. Am84590

39. Ccg-269339

40. Cs-1540

41. As-75035

42. Ba164152

43. Glycine, N-((2s)-2-(((3r,4r)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl)methyl)-1-oxo-3-phenylpropyl)-, Dihydrate

44. Glycine, N-(2-((4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl)methyl)-1-oxo-3-phenylpropyl)-, Dihydrate, (3r-(1(s*),3alpha,4alpha))-

45. Glycine, N-(2-((4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl)methyl)-1-oxo-3-phenylpropyl)-,dihydrate, (3r-(1(s*),3-alpha,4-alpha))-

46. D02878

47. D70720

48. 098a381

49. A882054

50. (2s, 3r, 4r)[[2-[[4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl ]methyl]-1-oxo-3-phenylpropyl]-amino]acetic Acid Dihydrate

51. 2-((s)-2-benzyl-3-((3r,4r)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl)propanamido)acetic Acid Dihydrate

52. 2-[(2s)-2-{[(3r,4r)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]methyl}-3-phenylpropanamido]acetic Acid Dihydrate

53. 2-[(2s)-2-benzyl-3-[(3r,4r)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]propanamido]acetic Acid Dihydrate

54. Glycine, N-(2-((4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl)methyl)-1-oxo-3-phenylpropyl)-, Dihydrate, (3r-(1(s*),3.alpha.,4.alpha.))-

2.4 Create Date
2005-08-08
3 Chemical and Physical Properties
Molecular Weight 460.6 g/mol
Molecular Formula C25H36N2O6
Hydrogen Bond Donor Count5
Hydrogen Bond Acceptor Count7
Rotatable Bond Count8
Exact Mass460.25733687 g/mol
Monoisotopic Mass460.25733687 g/mol
Topological Polar Surface Area91.9 Ų
Heavy Atom Count33
Formal Charge0
Complexity606
Isotope Atom Count0
Defined Atom Stereocenter Count3
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count3
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Gastrointestinal Agents

Drugs used for their effects on the gastrointestinal system, as to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion. (See all compounds classified as Gastrointestinal Agents.)


ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty